— Christine M. Kukka, Project Manager, HBV Advocate
A small study, presented at the 2014 Liver Congress found that
HBeAg-positive children who were treated with vitamin E (15
mg/kg/daily) for 12 months achieved higher rates of HBeAg conversion,
lower viral loads and normal ALT levels than did untreated children.
The Italian study followed 46 children treated
with vitamin E for 12 months and six children who were not for a total
of 24 months, including 12 months of monitoring after treatment ended.
"A complete response (normal ALT levels and HBV
DNA under 2,000 IU/mL) was achieved in eight of the 23 children treated
with vitamin E (33%) compared to only one of 23 children who were not
treated (4%).
HBeAg seroconversion was also higher in the
vitamin E-treated group, however specific numbers were not included in
the abstract's description of the study. (Abstract P1088)
Source: www.hbvadvocate.org/EASL_2014_Abstracts.pdf
HBV Journal Review
May 1, 2014, Vol 11, no 5
http://www.hbvadvocate.org/news/HBJ11.5.htmLabels: reducing liver damage, Vitamin E
